Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Afghanistan (2)
Argentina (7)
Armenia (1)
Australia (11)
Austria (159)
Bangladesh (1)
Belarus (1)
Belgium (231)
Brazil (6)
Bulgaria (11)
Burkina Faso (1)
Cameroon (5)
Canada (9)
Chile (3)
China (10)
Colombia (1)
Costa Rica (1)
Croatia (12)
Cyprus (8)
Czech Republic (82)
Côte d’Ivoire (1)
Denmark (169)
Ecuador (2)
Egypt (2)
Estonia (39)
Ethiopia (3)
Finland (111)
Former Yugoslav Republic of Macedonia (1)
France (472)
Gabon (3)
Germany (595)
Greece (71)
Guinea (1)
Guinea-Bissau (1)
Hong Kong (1)
Hungary (80)
Iceland (11)
India (8)
Ireland (57)
Israel (102)
Italy (388)
Japan (1)
Kenya (3)
Latvia (13)
Lebanon (1)
Lithuania (12)
Luxembourg (7)
Malawi (1)
Mali (1)
Mexico (4)
Netherlands (334)
Nigeria (2)
Norway (58)
Pakistan (1)
Peru (1)
Poland (89)
Portugal (51)
Romania (10)
Russia (27)
Senegal (1)
Singapore (2)
Slovakia (20)
Slovenia (31)
South Africa (16)
South Korea (1)
Spain (262)
Sudan (1)
Sweden (288)
Switzerland (217)
Tanzania (3)
Thailand (2)
The Gambia (1)
Tunisia (2)
Turkey (10)
Uganda (3)
Ukraine (7)
United Kingdom (488)
United States (17)
Venezuela (1)
Vietnam (2)
Zambia (2)
Zimbabwe (1)

Language

Deutsch (300)
English (1213)
Español (300)
Français (300)
Italiano (300)
Polski (295)

Advanced search

Results 71 - 80 of 2708
Results/page:
|< < 3 4 5 6 7 89 10 11 12 > >| 
Adrenoleukodystrophy unravelled
The EU-funded X-ALD project undertook an initiative to understand the mechanisms responsible for the pathogenesis of adrenoleukodystrophy (ALD). The gene therapy approach for treating ALD developed during the study brings hope to many young boys that have inherited the disease.
Programme: FP6-LIFESCIHEALTH
Record Number: 89020
Last updated on: 2012-07-24
Available languages: DE, EN, ES, FR, IT, PL
L'adrénoleucodystrophie dévoilée
Le projet X-ALD financé par l'UE s'est attaché à comprendre les mécanismes responsables de l'adrénoleucodystrophie (ALD). L'approche par thérapie génique conçue durant le projet représente un espoir pour les nombreux jeunes garçons qui ont hérité de cette maladie.
Programme: FP6-LIFESCIHEALTH
Record Number: 89020
Last updated on: 2012-07-24
Available languages: DE, EN, ES, FR, IT, PL
Svelata l'adrenoleucodistrofia
[RESULT IN BRIEF] Svelata l'adrenoleucodistrofia
Il progetto X-ALD finanziato dall'UE ha intrapreso un'iniziativa volta a comprendere i meccanismi responsabili della patogenesi dell'adrenoleucodistrofia (ALD). L'approccio della terapia genica per il trattamento dell'ALD sviluppato durante lo studio genera speranza in molti giovani che hanno ereditato la malattia.
Programme: FP6-LIFESCIHEALTH
Record Number: 89020
Last updated on: 2012-07-24
Available languages: DE, EN, ES, FR, IT, PL
Zagadka adrenoleukodystrofii rozwikłana
W ramach finansowanego przez UE projektu X-ALD podjęto inicjatywę, której celem było zrozumienie mechanizmów odpowiadających za patogenezę adrenoleukodystrofii (ALD). Terapia genowa w leczeniu ALD opracowana w ramach projektu przynosi nadzieję wielu młodym chłopcom, którzy odziedziczyli tę chorobę.
Programme: FP6-LIFESCIHEALTH
Record Number: 89020
Last updated on: 2013-05-20
Available languages: DE, EN, ES, FR, IT, PL
Neue Erkenntnisse zu Adrenoleukodystrophie
Das EU-finanzierte Projekt X-ALD untersuchte die pathogenen Mechanismen der Adrenoleukodystrophie (ALD). Der gentherapeutische Ansatz, der in der Studie zur Behandlung von ALD entwickelt wurde, soll all jenen jungen Männern helfen, die erblich bedingt an der Erkrankung leiden.
Programme: FP6-LIFESCIHEALTH
Record Number: 89020
Last updated on: 2012-07-24
Available languages: DE, EN, ES, FR, IT, PL
Tecnología de mimótopos para lograr una vacuna contra el Alzheimer
Investigadores europeos han creado una vacuna para la enfermedad de Alzheimer. Esta vacuna posee especificidad contra ciertos péptidos (beta-amiloides, BA) presentes en las placas características de este trastorno neurodegenerativo.
Programme: FP6-LIFESCIHEALTH
Record Number: 89772
Last updated on: 2012-11-14
Available languages: DE, EN, ES, FR, IT, PL
Mimotope technology for Alzheimer's vaccine
European researchers have developed a vaccine for Alzheimer's disease (AD). The vaccine targets certain peptides (beta-amyloids (BAs)) in the plaques that are characteristic of the neurodegenerative condition.
Programme: FP6-LIFESCIHEALTH
Record Number: 89772
Last updated on: 2012-11-14
Available languages: DE, EN, ES, FR, IT, PL
La technologie du mimotope pour le vaccin contre l'Alzheimer
Des chercheurs européens ont développé un vaccin contre la maladie d'Alzheimer (MA). Le vaccin cible certains peptides (les bêta-amyloïdes (BA)) dans les agrégats, véritables caractéristiques de la maladie neurodégénérative.
Programme: FP6-LIFESCIHEALTH
Record Number: 89772
Last updated on: 2012-11-14
Available languages: DE, EN, ES, FR, IT, PL
Technologia mimotopowa w szczepionce przeciw chorobie Alzheimera
Europejscy naukowcy opracowali szczepionkę przeciw chorobie Alzheimera (AD). Celem szczepionki są określone peptydy (beta-amyloidy (BA)) w płytkach, które są charakterystyczne dla stanów neurozwyrodnieniowych.
Programme: FP6-LIFESCIHEALTH
Record Number: 89772
Last updated on: 2013-05-20
Available languages: DE, EN, ES, FR, IT, PL
Tecnologia basata su mimotopi per un vaccino contro il morbo di Alzheimer
I ricercatori europei hanno sviluppato un vaccino per il morbo di Alzheimer. Il nuovo preparato prende di mira alcuni peptidi (betaamiloidi, BA) delle placche caratteristici di questa condizione neurodegenerativa.
Programme: FP6-LIFESCIHEALTH
Record Number: 89772
Last updated on: 2012-11-14
Available languages: DE, EN, ES, FR, IT, PL
|< < 3 4 5 6 7 89 10 11 12 > >| 
List retrieved on: 2017-03-30
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top